Heartland Express, Inc. Declares Regular Quarterly Dividend
/
Date14 Mar 2017
NORTH LIBERTY, Iowa, March 14, 2017 (GLOBE NEWSWIRE) — The Board of Directors of Heartland Express, Inc. (Nasdaq:HTLD) announced today the declaration of a regular... Read More →
Neos Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
/
Date14 Mar 2017
DALLAS and FORT WORTH, Texas, March 14, 2017 (GLOBE NEWSWIRE) — Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative... Read More →
Trinity Biotech announces Quarter 4 and Fiscal Year 2016 Financial Results
/
Date14 Mar 2017
DUBLIN, Ireland, March 14, 2017 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical... Read More →
Wabtec Acquires ATP, A Manufacturer Of Engineered Freight Car Components
/
Date14 Mar 2017
WILMERDING, Pa., March 14, 2017 (GLOBE NEWSWIRE) — Wabtec Corporation (NYSE:WAB) has acquired Aero Transportation Products (ATP), a manufacturer of engineered freight car components. The... Read More →
Roper Technologies Announces Dividend
/
Date14 Mar 2017
SARASOTA, Fla., March 14, 2017 (GLOBE NEWSWIRE) — Roper Technologies, Inc. (NYSE:ROP) announced that its Board of Directors has approved a dividend of $0.35 per... Read More →
Synalloy Reports Fourth Quarter 2016 Results: Moderated Declines Year Over Year and Increased 4th Quarter Activity Points To Building Recovery
/
Date14 Mar 2017
RICHMOND, Va., March 14, 2017 (GLOBE NEWSWIRE) — Synalloy Corporation (Nasdaq:SYNL), today announced net sales for the fourth quarter of 2016 of $33.1 million. This... Read More →
Clearside Biomedical, Inc. Announces Fourth Quarter And Full Year 2016 Financial Results
/
Date14 Mar 2017
ALPHARETTA, Ga., March 14, 2017 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, today... Read More →
IFMI Reports Fourth Quarter & Full Year 2016 Financial Results
/
Date14 Mar 2017
Fourth Quarter Operating Income of $2.5 million Fourth Quarter Net Income of $0.4 million, or $0.02 per Diluted Share Full Year Operating Income of $8.6... Read More →
Albireo Reports 2016 Financial Results
/
Date14 Mar 2017
Promising Phase 2 data for A4250 in pediatric cholestatic liver disease Initiation of A4250 Phase 3 trial planned for 2H 2017 JNDA filing for elobixibat... Read More →
Intellia Therapeutics Announces Fourth Quarter and Full-Year 2016 Financial Results
/
Date14 Mar 2017
First to demonstrate single dose, in vivo results, showing approximately 97 percent reduction in serum transthyretin protein levels Further established a comprehensive platform, including a... Read More →